12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists.

      Biochemical and Biophysical Research Communications
      Analgesics, pharmacology, Animals, Animals, Newborn, COS Cells, Cells, Cultured, Cercopithecus aethiops, Dose-Response Relationship, Drug, Fluoxetine, Ganglia, Spinal, cytology, drug effects, metabolism, Glutamic Acid, Mice, Neurons, Patch-Clamp Techniques, Potassium Channels, Rats, Rats, Sprague-Dawley, Receptors, G-Protein-Coupled, agonists, Triazines

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dorsal root ganglion (DRG) neurons express mRNAs for numerous two-pore domain K(+) (K(2P)) channels and G-protein coupled receptors (GPCR). Recent studies have shown that TRESK is a major background K(+) channel in DRG neurons. Here, we demonstrate the pharmacological properties of TRESK, including GPCR agonist-induced effects on DRG neurons. TRESK mRNA was highly expressed in DRG compared to brain and spinal cord. Similar to cloned TRESK, native TRESK was inhibited by acid and arachidonic acid (AA), but not zinc. Native TRESK was also activated by GPCR agonists such as acetylcholine, glutamate, and histamine. The glutamate-activated TRESK was blocked by lamotrigine in DRG neurons. In COS-7 cells transfected with mouse TRESK, 30 microM lamotrigine inhibited TRESK by approximately 50%. Since TRESK is target of modulation by acid, AA, GPCR agonists, and lamotrigine, it is likely to play an active role in the regulation of excitability in DRG neurons.

          Related collections

          Author and article information

          Comments

          Comment on this article